Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Phipps, P.
Right arrow Articles by Gonda, I
Right arrow Search for Related Content
PubMed
Right arrow Articles by Phipps, P.
Right arrow Articles by Gonda, I

Chest, Vol 97, 1327-1332, Copyright © 1990 by American College of Chest Physicians

ARTICLES

Droplets produced by medical nebulizers. Some factors affecting their size and solute concentration

PR Phipps and I Gonda
Department of Pharmacy, Sydney University, Australia.

The effect of nebulizer solution temperature and dilution air humidity on the size and solute concentration of aqueous aerosol droplets were studied. Four combinations of jet-nebulizers with air compressors or oxygen sources and one ultrasonic nebulizer were tested. The temperature to which the nebulizer solution of each system fell during generation was measured. The nebulizers were then kept at set temperatures, generated aerosols collected and either droplet size or solute concentration measured. The droplet solute concentration was found to increase. The droplet size decreased along with the droplet solute concentration increase. The ultrasonic nebulizer also was tested: its high output made the concentration of the solution in the droplets much more stable. However, the proportion of droplets depositing in the tubing and valves changed markedly with aerosol flow rate. The potential for large changes in droplet solute concentration, droplet size and output during nebulization should be considered in therapeutic and diagnostic applications of nebulized aerosols.


This article has been cited by other articles:


Home page
 NeoReviewsHome page
S. R. Hintz
Pharmacology Review: Bronchodilator Aerosol Therapy in the Preterm Infant
NeoReviews, September 1, 2003; 4(9): e245 - 249.
[Full Text] [PDF]

Home page
 CMAJHome page
Inhalation devices and propellants
Can. Med. Assoc. J., November 1, 1999; 161(90111): s44 - 50.
[Full Text]

Home page
 ChestHome page
D. R. Hess, F. L. Acosta, R. H. Ritz, R. M. Kacmarek, and C. A. Camargo Jr
The Effect of Heliox on Nebulizer Function Using a {beta}-Agonist Bronchodilator
Chest, January 1, 1999; 115(1): 184 - 189.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
G. A. FONTANA, T. PANTALEO, F. LAVORINI, F. BENVENUTI, and S. GANGEMI
Defective Motor Control of Coughing in Parkinson's Disease
Am. J. Respir. Crit. Care Med., August 1, 1998; 158(2): 458 - 464.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1990 by the American College of Chest Physicians.